The prognostic utility of pre‐treatment neutrophil‐to‐lymphocyte‐ratio (NLR) in colorectal cancer: a systematic review and meta‐analysis
M Naszai, A Kurjan, TS Maughan - Cancer Medicine, 2021 - Wiley Online Library
Background Inflammation is a hallmark of cancer, and systemic markers of inflammation are
increasingly recognised as negative prognostic factors for clinical outcome. Neutrophil‐to …
increasingly recognised as negative prognostic factors for clinical outcome. Neutrophil‐to …
[HTML][HTML] Tumor microenvironment in metastatic colorectal cancer: the arbitrator in patients' outcome
C Galindo-Pumariño, M Collado, M Herrera, C Peña - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer accounts for approximately 10% of all annually
diagnosed cancers worldwide being liver metastasis, the most common cause of death in …
diagnosed cancers worldwide being liver metastasis, the most common cause of death in …
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
C Mohindroo, M Hasanov, JE Rogers, W Dong… - Cancer …, 2021 - Wiley Online Library
Recent studies defined a potentially important role of the microbiome in modulating
pancreatic ductal adenocarcinoma (PDAC) and responses to therapies. We hypothesized …
pancreatic ductal adenocarcinoma (PDAC) and responses to therapies. We hypothesized …
[HTML][HTML] Clinical significance of glucose to lymphocyte ratio (GLR) as a prognostic marker for patients with pancreatic cancer
A Zhong, C Cheng, J Kai, R Lu, L Guo - Frontiers in Oncology, 2020 - frontiersin.org
Glucose metabolism and systemic inflammation have been associated with cancer
aggressiveness and patient prognosis in various malignancies. This study aimed to evaluate …
aggressiveness and patient prognosis in various malignancies. This study aimed to evaluate …
Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma
Aim: To evaluate the prognostic significance of neutrophil lymphocyte ratio, prognostic
nutritional index, systemic immune-inflammation index (SII) and B2M in Hodgkin Lymphoma …
nutritional index, systemic immune-inflammation index (SII) and B2M in Hodgkin Lymphoma …
[HTML][HTML] Change in the neutrophil‑to‑lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer
T Nemoto, S Endo, N Isohata… - Molecular and …, 2021 - spandidos-publications.com
The neutrophil‑to‑lymphocyte ratio (NLR) has been reported to be an independent
prognostic factor of unresectable advanced or metastatic colorectal cancer (uCRC) …
prognostic factor of unresectable advanced or metastatic colorectal cancer (uCRC) …
[HTML][HTML] Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood
Y Li, H Wu, C Xing, X Hu, F Zhang, Y Peng, Z Li… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background: Many indicators of peripheral blood in routine blood test (BRT) results of
colorectal cancer (CRC) patients are related to prognosis. Currently, indexes such as NLR …
colorectal cancer (CRC) patients are related to prognosis. Currently, indexes such as NLR …
The pre-treatment lymphocyte-to-monocyte ratio predicts efficacy in metastatic colorectal cancer treated with TAS-102 and bevacizumab
H Kuramochi, T Yamada, Y Yoshida… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: Our multicenter phase II TAS-CC3 study demonstrated favorable median
progression-free survival (PFS) and overall survival (OS) of 32 metastatic colorectal cancer …
progression-free survival (PFS) and overall survival (OS) of 32 metastatic colorectal cancer …
Trifluridine/tipiracil in metastatic colorectal cancer: a UK multicenter real-world analysis on efficacy, safety, predictive and prognostic factors
C Stavraka, A Pouptsis, A Synowiec, V Angelis… - Clinical Colorectal …, 2021 - Elsevier
Background The orally administered combination trifluridine/tipiracil has been approved as
third line treatment in mCRC, demonstrating survival benefit and acceptable toxicity profile in …
third line treatment in mCRC, demonstrating survival benefit and acceptable toxicity profile in …
Diagnostic value of albumin to fibrinogen ratio in cervical Cancer
L Huang, Z Mo, L Zhang, S Qin… - … International Journal of …, 2020 - journals.sagepub.com
Background: Albumin to fibrinogen ratio (AFR) play a crucial role in the progression and
prognosis of many malignant tumors. This study aimed to comprehensively assess the …
prognosis of many malignant tumors. This study aimed to comprehensively assess the …